ATE192040T1 - Wirkstoff gegen arteriosklerose - Google Patents

Wirkstoff gegen arteriosklerose

Info

Publication number: ATE192040T1
Authority: AT; Austria
Prior art keywords: active ingredients; proliferation; smooth muscle; muscle cells; arteriosclerosis
Prior art date: 1994-05-31

Application number

AT95909975T

Other languages

English (en)

Inventor

Hisao Tomioka

Hidefumi Ohsawa

Masao Moroi

T Kawashima

Original Assignee

Mitsubishi Tokyo Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-31

Filing date

1995-02-24

Publication date

2000-05-15

1995-02-24 Application filed by Mitsubishi Tokyo Pharm Inc filed Critical Mitsubishi Tokyo Pharm Inc

2000-05-15 Application granted granted Critical

2000-05-15 Publication of ATE192040T1 publication Critical patent/ATE192040T1/de

Links

206010003210 Arteriosclerosis Diseases 0.000 title abstract 2
208000011775 arteriosclerosis disease Diseases 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 title 1
230000035755 proliferation Effects 0.000 abstract 2
210000004509 vascular smooth muscle cell Anatomy 0.000 abstract 2
DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 abstract 1
KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000003449 preventive effect Effects 0.000 abstract 1
208000037803 restenosis Diseases 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)

AT95909975T 1994-05-31 1995-02-24 Wirkstoff gegen arteriosklerose ATE192040T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP11914694		1994-05-31
PCT/JP1995/000277 WO1995032714A1 (en)	1994-05-31	1995-02-24	Arteriosclerosis depressant

Publications (1)

Publication Number	Publication Date
ATE192040T1 true ATE192040T1 (de)	2000-05-15

Family

ID=14754063

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95909975T ATE192040T1 (de)	1994-05-31	1995-02-24	Wirkstoff gegen arteriosklerose

Country Status (8)

Country	Link
US (1)	US5840741A (de)
EP (1)	EP0766963B1 (de)
KR (1)	KR970703147A (de)
AT (1)	ATE192040T1 (de)
AU (1)	AU702727B2 (de)
CA (1)	CA2190750A1 (de)
DE (1)	DE69516519T2 (de)
WO (1)	WO1995032714A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4171303B2 (ja) *	2001-02-26	2008-10-22	田辺三菱製薬株式会社	腎疾患・腎不全の予防剤及び／又は治療剤
US20070225301A1 (en) *	2006-02-13	2007-09-27	Astion Inflammation Aps	Treatment of acne and other diseases
EA200900815A1 (ru) *	2006-12-18	2009-12-30	Кардос Аб	Новая комбинация, предназначенная для лечения воспалительных нарушений
US20100168137A1 (en) *	2006-12-20	2010-07-01	Johan Raud	Combination for use in the treatment of inflammatory disorders
WO2009007680A2 (en)	2007-07-11	2009-01-15	Cardoz Ab	Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders
WO2009007679A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
WO2009007675A2 (en) *	2007-07-11	2009-01-15	Cardoz Ab	Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
EP2175845A2 (de) *	2007-07-11	2010-04-21	Cardoz AB	Neue kombination zur verwendung bei der behandlung von entzündlichen erkrankungen
DE102014222804B4 (de)	2014-11-07	2023-12-28	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Vorrichtung und Verfahren zum Bestimmen einer Wandschubspannung und System zur Erkennung von Arteriosklerose

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES390598A1 (es) *	1970-05-21	1973-06-16	Pfizer	Un procedimiento para preparar 4-amino - 6,7,8 - trialcoxi-quinazolinas sustituidas en la posicion 2.
JP3116970B2 (ja) *	1991-06-12	2000-12-11	三菱東京製薬株式会社	ペミロラストカリウムの徐放性製剤

1995
- 1995-02-24 WO PCT/JP1995/000277 patent/WO1995032714A1/ja not_active Ceased
- 1995-02-24 AT AT95909975T patent/ATE192040T1/de not_active IP Right Cessation
- 1995-02-24 AU AU18239/95A patent/AU702727B2/en not_active Ceased
- 1995-02-24 CA CA002190750A patent/CA2190750A1/en not_active Abandoned
- 1995-02-24 EP EP95909975A patent/EP0766963B1/de not_active Expired - Lifetime
- 1995-02-24 DE DE69516519T patent/DE69516519T2/de not_active Expired - Fee Related
- 1995-02-24 US US08/737,680 patent/US5840741A/en not_active Expired - Fee Related
- 1995-02-24 KR KR1019960706787A patent/KR970703147A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
AU1823995A (en)	1995-12-21
EP0766963A4 (de)	1997-10-29
AU702727B2 (en)	1999-03-04
US5840741A (en)	1998-11-24
CA2190750A1 (en)	1995-12-07
EP0766963B1 (de)	2000-04-26
DE69516519D1 (de)	2000-05-31
KR970703147A (ko)	1997-07-03
EP0766963A1 (de)	1997-04-09
DE69516519T2 (de)	2000-10-12
WO1995032714A1 (en)	1995-12-07

Similar Documents

Publication	Publication Date	Title
ATE370138T1 (de)	2007-09-15	Neue imidazopyridine und ihre verwendung
MY107341A (en)	1995-11-30	Novel hydroxamic acid and n-hydroxyurea derivatives and their use
DE69410121D1 (en)	1998-06-10	Dihydro pyrazolopyrrole
EP0939627A4 (de)	2000-10-04	Pentafluorobenzensulfonamide und analoge
TR199801642T2 (xx)	1998-11-23	Tedavide faydal� olan karbamik asitlerin azabisiklik esterleri.
TR200000129T2 (tr)	2000-07-21	Yepyeni spiroazabisiklik heterosiklik bileşikler.
SE9604786D0 (sv)	1996-12-20	New compounds
DE69519385D1 (de)	2000-12-14	Chinazolinon-arzneimittel sowie deren verwendung
TR199802060T2 (xx)	1999-01-18	Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
NZ513096A (en)	2003-01-31	Compositions for treating inflammatory response
TR199902495T2 (xx)	2000-07-21	Bile�imler.
ECSP055809A (es)	2005-08-11	Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4
ATE161531T1 (de)	1998-01-15	Acridine-1,8-dionderivate als therapeutisches mittel
DE69223736D1 (de)	1998-02-05	Acridine-1,8-Dionderivate als therapeutisches Mittel
DE69516519D1 (de)	2000-05-31	Wirkstoff gegen arteriosklerose
MY133785A (en)	2007-11-30	Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
CA2386685A1 (en)	2001-05-31	Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
ATE297926T1 (de)	2005-07-15	Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
DE69103773D1 (de)	1994-10-06	Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE69402004D1 (de)	1997-04-17	Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
NO20055517L (no)	2006-01-18	4-,6-O 7-hydroksyindoler med N-oksidgrupper og anvendelse av disse som terapeutiske midler
EP1325918A4 (de)	2004-03-10	Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten
ES2168119T3 (es)	2002-06-01	Derivados de quinoxalina para el tratamiento de tinnitus.
ATE81466T1 (de)	1992-10-15	Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.

Legal Events

Date	Code	Title	Description
2000-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties